The CDC considers this the third wave of overdose deaths in the growing epidemic, characterized by a surge in synthetic opioid overdoses, following prescription opioid deaths (first wave) and heroin deaths (second wave). The death rate for synthetic opioids doubled to 6.2 per 100,000 people in 2016.
Because fentanyl, a highly potent synthetic opioid, is increasingly mixed with other opioid and benzodiazepine pills, heroin and cocaine, the CDC suspects fentanyl is also contributing to rising death rates among those substances.
The Cabinet for Health and Family Services (CHFS) is sponsoring and funding two free training sessions on the American Society of Addiction Medicine (ASAM) Treatment of Opioid Use Disorder (OUD) Course. The course is designed to help practitioners who work with opioid use disorder patients to obtain a waiver to prescribe buprenorphine in office-based treatment of OUDs.
The first training will be on February 24 in Lexington, and the second training will be on March 10 in Hazard. Visit the corresponding links for session details and registration information.
Post Office Box 436629
Louisville, Kentucky 40253-6629